Conversely, we found that palbociclib possesses additional activity to induce HCC cell apoptosis compared to the other high‐specificity CDK4/6 inhibitors, ribociclib and abemaciclib (Fig. 4). The gene discussed is CDK4; the disease is hepatocellular carcinoma.